Nyse Cc News Today

Chemours (NYSE:CC – Get Free Report) issued its quarterly earnings data on Tuesday. The specialty chemicals company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.07, Briefing.com reports. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. The company had revenue […]

Chemours (NYSE:CC – Get Free Report) issued its earnings results on Tuesday. The specialty chemicals company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.07, Briefing.com reports. The business had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.35 billion. Chemours had a positive […]

Chemours (NYSE:CC – Get Free Report) announced its quarterly earnings data on Tuesday. The specialty chemicals company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.07, Briefing.com reports. The company had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.35 billion. Chemours had a […]

Chemours (NYSE:CC – Get Free Report) will release its earnings data after the market closes on Tuesday, April 30th. Analysts expect Chemours to post earnings of $0.25 per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link. Chemours (NYSE:CC – Get Free Report) last […]

Bryn Mawr Capital Management LLC boosted its holdings in The Chemours Company (NYSE:CC – Free Report) by 135.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 27,205 shares of the specialty chemicals company’s stock after buying an additional 15,662 shares during the period. Bryn Mawr Capital Management […]

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA decreased its holdings in shares of The Chemours Company (NYSE:CC – Free Report) by 5.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,162 shares of the specialty chemicals company’s stock after […]

Shares of The Chemours Company (NYSE:CC – Get Free Report) have received a consensus rating of “Hold” from the eight research firms that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and one has assigned a buy recommendation to […]

Shares of The Chemours Company (NYSE:CC – Get Free Report) gapped up before the market opened on Wednesday after UBS Group raised their price target on the stock from $21.00 to $28.00. The stock had previously closed at $27.62, but opened at $28.25. UBS Group currently has a neutral rating on the stock. Chemours shares […]

Chemours (NYSE:CC – Get Free Report) had its target price increased by research analysts at UBS Group from $21.00 to $28.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s price objective would suggest a potential upside of 1.38% from […]

Mirabella Financial Services LLP purchased a new position in shares of The Chemours Company (NYSE:CC – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,107 shares of the specialty chemicals company’s stock, valued at approximately $284,000. A number of […]